APA (7th ed.) Citation

AS, A., NM, A., HA, A., RM, A., MA, A., & C, P. (2016). Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways. The Journal of pharmacy and pharmacology, 68(2), 219. https://doi.org/10.1111/jphp.12504

Chicago Style (17th ed.) Citation

AS, Al-Onazi, Al-Rasheed NM, Attia HA, Ahmed RM, Al-Amin MA, and Poizat C. "Ruboxistaurin Attenuates Diabetic Nephropathy via Modulation of TGF-β1/Smad and GRAP Pathways." The Journal of Pharmacy and Pharmacology 68, no. 2 (2016): 219. https://doi.org/10.1111/jphp.12504.

MLA (9th ed.) Citation

AS, Al-Onazi, et al. "Ruboxistaurin Attenuates Diabetic Nephropathy via Modulation of TGF-β1/Smad and GRAP Pathways." The Journal of Pharmacy and Pharmacology, vol. 68, no. 2, 2016, p. 219, https://doi.org/10.1111/jphp.12504.